Advertisement
Advertisement
LIMN
Liminatus Pharma, Inc. Class A Common Stock
2.54
USDSponsored
-0.09
-3.42%
Nov 06, 15:57 UTC -5
Closed
Pre-Market
2.80
+0.26
+10.24%
Liminatus Pharma, Inc. Class A Common Stock (LIMN)
Liminatus Pharma, Inc. Class A Common Stock Financial Snapshot
| Market Cap | 3.76M |
| Beta | 4.89 |
| Earnings Per Share (EPS) | -23.50 |
| Price-to-Book (P/B) Ratio | 9.45 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 479.85% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -- |
| Current Ratio | 1.12% |
| Free Cash Flow | -2.99M |
